Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

532 ARTÍCULOS , VIENDO DEL 121 AL 135

Incomplete penetrance in familial Alzheimer's disease with PSEN1 Ala260Gly mutation

Piaceri I, Chiari A, Galli C, Bagnoli S, Ferrari C, Saavedra ST, Molinari MA, Vinceti G, Sorbi S, Nacmias B.

Neurol Sci. 2020 Aug;41(8):2263-2266. doi: 10.1007/s10072-020-04421-6. Epub 2020 Apr 23.

Substrate recruitment by γ-secretase

Fukumori A, Feilen LP, Steiner H.

Semin Cell Dev Biol. 2020 Sep;105:54-63. doi: 10.1016/j.semcdb.2020.03.006. Epub 2020 Apr 22.

11β-hydroxysteroid dehydrogenase type 1 inhibitor use in human disease-a systematic review and narrative synthesis

Gregory S, Hill D, Grey B, Ketelbey W, Miller T, Muniz-Terrera G, Ritchie CW.

Metabolism. 2020 Jul;108:154246. doi: 10.1016/j.metabol.2020.154246. Epub 2020 Apr 23.

A systematic review on anti-Alzheimer's disease activity of prescription Kangen-karyu

Paudel P, Park CH, Jung HA, Yokozawa T, Choi JS.

Drug Discov Ther. 2020 May 6;14(2):61-66. doi: 10.5582/ddt.2020.03013. Epub 2020 Apr 24.

Benefits and Harms of Prescription Drugs and Supplements for Treatment of Clinical Alzheimer-Type Dementia

Fink HA, Linskens EJ, MacDonald R, Silverman PC, McCarten JR, Talley KMC, Forte ML, Desai PJ, Nelson VA, Miller MA, Hemmy LS, Brasure M, Taylor BC, Ng W, Ouellette JM, Sheets KM, Wilt TJ, Butler M.

Ann Intern Med. 2020 May 19;172(10):656-668. doi: 10.7326/M19-3887. Epub 2020 Apr 28.

Current Status of Drug Targets and Emerging Therapeutic Strategies in the Management of Alzheimer's Disease

Ghosh S, Durgvanshi S, Agarwal S, Raghunath M, Sinha JK.

Curr Neuropharmacol. 2020;18(9):883-903. doi: 10.2174/1570159X18666200429011823.

Calcium-activated potassium channels: implications for aging and age-related neurodegeneration

Trombetta-Lima M, Krabbendam IE, Dolga AM.

Int J Biochem Cell Biol. 2020 Jun;123:105748. doi: 10.1016/j.biocel.2020.105748. Epub 2020 Apr 27.

Pharmacological approaches to mitigate neuroinflammation in Alzheimer's disease

Uddin MS, Kabir MT, Mamun AA, Barreto GE, Rashid M, Perveen A, Ashraf GM.

Int Immunopharmacol. 2020 Jul;84:106479. doi: 10.1016/j.intimp.2020.106479. Epub 2020 Apr 27.

Successive cleavage of β-amyloid precursor protein by γ-secretase

Funamoto S, Tagami S, Okochi M, Morishima-Kawashima M.

Semin Cell Dev Biol. 2020 Sep;105:64-74. doi: 10.1016/j.semcdb.2020.04.002. Epub 2020 Apr 27.

The current landscape in Alzheimer's disease research and drug discovery

Devenish SRA.

Drug Discov Today. 2020 Jun;25(6):943-945. doi: 10.1016/j.drudis.2020.04.002. Epub 2020 Apr 28.

Alzheimer's Disease and Functional Foods: An Insight on Neuroprotective Effect of its Combination

Hasnieza Mohd Rosli N, Mastura Yahya H, Shahar S, Wahida Ibrahim F, Fadilah Rajab N.

Pak J Biol Sci. 2020 Jan;23(5):575-589. doi: 10.3923/pjbs.2020.575.589.

Opportunities for multiscale computational modelling of serotonergic drug effects in Alzheimer's disease

Joshi A, Wang DH, Watterson S, McClean PL, Behera CK, Sharp T, Wong-Lin K.

Neuropharmacology. 2020 Sep 1;174:108118. doi: 10.1016/j.neuropharm.2020.108118. Epub 2020 May 4.

A Systematic Review of Current Progresses in the Nucleic Acid-Based Therapies for Neurodegeneration with Implications for Alzheimer's Disease

Ghaffari M, Sanadgol N, Abdollahi M.

Mini Rev Med Chem. 2020;20(15):1499-1517. doi: 10.2174/1389557520666200513122357.

Therapeutic Potential of Phosphodiesterase Inhibitors against Neurodegeneration: The Perspective of the Medicinal Chemist

Ribaudo G, Ongaro A, Zagotto G, Memo M, Gianoncelli A.

ACS Chem Neurosci. 2020 Jun 17;11(12):1726-1739. doi: 10.1021/acschemneuro.0c00244. Epub 2020 May 28.

Pisa syndrome induced by switching of a choline-esterase inhibitor treatment from donepezil to galantamine: a case report

Mimura Y, Kurose S, Takata T, Tabuchi H, Mimura M, Funayama M.

BMC Neurol. 2020 May 13;20(1):183. doi: 10.1186/s12883-020-01769-2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias